Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 677 of 1,261
  1. US 9427434

    Coated preparation

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  2. US 9427381

    Dental curable composition, and method for producing same

    KURARAY NORITAKE DENTAL INC. · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  3. US 9428490

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  4. US 9428731

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    San Diego Regenerative Medicine Institute · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  5. US 9427423

    Fatty-acid based particles

    ATRIUM MEDICAL CORPORATION · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  6. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  7. US 9428561

    Polypeptide-polymer conjugates and methods of use thereof

    The Regents of the University of California · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  8. US 9428489

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  9. US 9428457

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  10. CA 2977090

    FORMULATIONS PHARMACEUTIQUES DE L'INHIBITEUR D'ESTERASE C1

    CSL BEHRING GMBH [DE] · Granted Aug 25, 2016 · Expires Aug 20, 2036

    granted
  11. US 9422339

    Immunomodulating cyclic compounds

    Aurigene Discovery Technologies Limited · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  12. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  13. US 9421240

    Compstatin analogs for treatment of neuropathic pain

    Apellis Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  14. US 9421185

    Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract

    The Regents of the University of California · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  15. US 9422271

    Pyrimidine compounds as tuberculosis inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  16. US 9422340

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  17. US 9421196

    Amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  18. US 9421194

    Lung targeting dual drug delivery system

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  19. US 9422562

    Compositions and methods for inhibiting expression of CD274/PD-L1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  20. US 9422556

    RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  21. US 9422522

    Method of producing adipocytes from fibroblast cells

    Regenertech Pty Limited · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  22. US 9422413

    Elastomer formulations comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  23. US 9422347

    Algal produced malarial transmission blocking vaccines

    The Regents of the University of California · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  24. US 9422529

    Alphavirus compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.